Moreover, patients with LAPTM4B *1 allele had a poorer prognosis than LAPTM4B *2 allele in total colon cancer cases (OS rate 33.8% vs. 50.5%, P = 0.0050) (Fig 2B). This evidence concerns the gene LAPTM4B and malignant colon neoplasm.